february 4, 2003 georgetown university medical center the anatomy

30
1 Center for Entrepreneurship Jerry Feigen “An Anatomy of a Deal” March 13, 2003 NIH Bio Business Group

Upload: freddy56

Post on 22-Nov-2014

555 views

Category:

Economy & Finance


4 download

DESCRIPTION

 

TRANSCRIPT

Page 1: February 4, 2003 Georgetown University Medical Center The Anatomy

1

Center for Entrepreneurship

Jerry Feigen

“An Anatomy of a Deal”

March 13, 2003

NIH Bio Business Group

Page 2: February 4, 2003 Georgetown University Medical Center The Anatomy

2

Anatomy of a Deal• VC History• Assessing Traditional Entrepreneurs Vs. The Scientific Research• What is a deal - Sources of Capital?• How is a deal put together - Venture Investors and Deal

Expectations? • Role of a Business Plan in Structuring a Deal• Making the Presentation – You are the Team – All Alone• Letter of Intent• Due Diligence• Valuation Negotiation• Term Sheet / Investment Agreement• Deal Closing• Post Closing Relationships – Danger Signals• Exit• Where are we going with Biotechnology and Life Science Deals?• Montgomery College Bio Science Technology Park – An Ecosystem• Macklin Partners, Potential Internships, Incubator Development

Page 3: February 4, 2003 Georgetown University Medical Center The Anatomy

3

VC HISTORYThe First 10 years - 1960’s - Chaos and ExperimentationSmall Business Investment Act of 1958 • Direct equity investments by SBICs permitted • Organization of NASBIC (1958) - National Association of Small Business

Investment Companies • Funding of SBICs when licensed - misuse of too much cash • Lack of significant oversight creating fraudulent transactions,

bootstrapping, conflicts • More focus toward “venture capital” than lending • Cyclical nature to managing SBIC portfolio evolved • Average rate of return of SBICs, March 1969 - 9.5% • Top 25% SBICs averaged 30% on invested capital • Data on portfolio growth showed employment increase of 25%,

gross revenues increase by 27% and profits by 27% • SBICs flowed $1.7 billion in 35,000 transactions • $40 million invested in technology deals • Creation of new “equity” transaction structures and legal precedence

for deals • Hot issue market of early 1960s showed significance of IPO

“exiting” and timing

Page 4: February 4, 2003 Georgetown University Medical Center The Anatomy

4

The Second Ten Years - 1970’s - A U.S. Venture Capital Industry Created

• Increased leverage to 3:1 and 4:1 for SBICs to target “venture” financings and total leverage available to single SBIC increased

• Legislative authority to raise private institutional and individual investor funds through Wall Street instead of government direct funding

- Full faith and credit of U.S.- 100% guarantee- Timely payments

• National Venture Capital Association formed in 1973; 70 members including majority of the largest SBICs

• First Annual Venture Capital Institute was created in 1974

• Investor funds from outside the U.S. to capitalize SBICs began to emerge – basically European

• Major hits - Apple Computer, Cray Research, Federal Express, Intel

• Bio Deals Begin – Amgen – Pitch Johnson, Brook Byers – First VC Leap into Biotech

• Shift from electronics of 1960’s to computers of 1970’s

• 1977 SBA Task Force Report - Life Cycle of Growth Companies - Regulatory Impact on Growing Firms - SEC, pension, tax, etc.

• “ERISA” and “Prudent Man” Pension Fund Restrictions

Page 5: February 4, 2003 Georgetown University Medical Center The Anatomy

5

• Between 1970 – 1980

– SBICs disbursed $1.8 billion in more than 21,000 transactions– SBICs invested almost $193 million in 556 technology deals with another $199 million from co-investors

• Non SBIC private venture funds invested $1.7 billion with pension funds providing 31% of funds raised by venture capital funds in 1979

• Capital Gains tax reduction from 49 1/2 to 28 % - 1978

• Entrepreneurs of 1970’s

– Bob Noyce - Intel Corp– Gene Amdahl - Amdahl Computers / Trilogy Investments– Steve Jobs - Apple Computer– Seymour Cray - Cray Research– Fred Smith - Federal Express – Bob Swanson - Genentech

• Life Sciences deals begin, but falter

Page 6: February 4, 2003 Georgetown University Medical Center The Anatomy

6

Decade Three - 1980s - Era of Not So Benign Neglect

• From Computers to Biotechnology• Small Business Innovation Research Grants - 1982 - Prototype / commercial

feasibility of U.S. technology• Capital Gains tax reduction 26% to 20%• SBICs cover most of the states• Small Business Investment Incentive Act of 1980 gives rise to Business

Development Companies - some are SBICs - tapping public investors• Section 385 of IRS Code - What’s debt and what’s equity?• SBA raises private capital for SBICs to $1 million• SBA oversight becomes limited because of lack of resources• Proposal to eliminate SBA in 1985• Stock Market collapse in 1987• Lack of interest in SBIC formations by private sector• In 1990 - SBICs had $1.7 billion in private capital and SBA leverage of

$790 million• Between 1981-1990 - SBICs invested $4.4 billion in 24,000 transactions with

more than $1.2 billion provided to “technology” firms• Pension funds provided almost 40% of the $24 billion committed to independent venture funds in the decade• Entrepreneur of the Decade - Bill Gates - Microsoft

Page 7: February 4, 2003 Georgetown University Medical Center The Anatomy

7

The Roaring 1990s

• Venture Capital in Retreat• SBICs - Revisited and Restructured - A Counter Cyclical Force• Internet Emerges - Government / Private Sector Partnership

Explodes• Longest Growth Cycle in History• Financial Deregulation After 60 Years• Global Merger Mania• Largest VC Returns Ever - Millionaires Abound• NASDAQ Goes Global• A New Entrepreneurial Economy

Page 8: February 4, 2003 Georgetown University Medical Center The Anatomy

8

2000 and Beyond - A New Millennium Begins

• IPOs and Dot Coms and the Economic Cycle Clash• Stock Market Down • VCs Freeze Investing - Limiteds Change Interests• U.S. Economy in Retreat• Geographic Shift in U.S. Focus for Funds / Angel Networks

Grow• VC Activity Outside U.S. Taking Leads in Early Stage Deals• First Round Venture Funding to Just $1.04 Billion During 2nd Quarter 2001 - Down 87% from last year• Terrorists Hit World Trade • Acceleration of Global Impact on Markets• Enron and the Fall Out for VC Deals• What’s Next ?????????

Page 9: February 4, 2003 Georgetown University Medical Center The Anatomy

9

Assessing Traditional Entrepreneurs Vs. The Scientific Research

• Total commitment, determination and perseverance• Drive to achieve and grow• Opportunity and goal oriented - realistic goal setting• Taking initiative and personal responsibility• Persistent problem solving / self imposed challenges• Awareness of self with sense of humor - optimistic• Seeks and uses feedback - good talkers / listeners• Internal locus of control - belief in themselves• Tolerance for ambiguity, stress and uncertainty• Calculated risk taker and risk sharer• High integrity and reliability• Copes with failure

Page 10: February 4, 2003 Georgetown University Medical Center The Anatomy

10

Page 11: February 4, 2003 Georgetown University Medical Center The Anatomy

11

Life Cycle of a Start-up

• Basic Steps and Pitfalls to Growing a Business

• The Agony and Ecstasy at Each Stage of Growth - A lonely existence

• Moving to Professional and Personal Rewards/Disappointments

• Bottom Line Measurements of Success or Failure - Economic vs. Personal Goals

Page 12: February 4, 2003 Georgetown University Medical Center The Anatomy

12

Capital Sources for Growing Enterprises - Cyclical Challenges

• Friends / Family / Angel Investors and Network• Government - Prototype and Feasibility - ATP,

SBIR, State Programs (MIPs), etc.• Venture Capital Firms - Which are the right

ones?• Endowments/Fund of Funds - Bio/Health related• Licensing Options - Pros and cons• Joint Venturing - Pros and cons• Corporate and Corporate Venturing Groups• International Balancing Acts

Page 13: February 4, 2003 Georgetown University Medical Center The Anatomy

13

Deal Expectations• Expectations

• Know and Keep Focus

What is a VC Investment Policy– Return on Investment– Economic Development– Technology– Deal Stage of Development

What Do Investors Expect• Timely Information - Truth– Regular Contact - No Surprises

What Do Entrepreneurs Expect– Money and Confrontation– Free Hand

Page 14: February 4, 2003 Georgetown University Medical Center The Anatomy

14

• Deal Flow

• Marketing - What Fund is or is Not• Sourcing The Right Deals• Referrals - Who do you Trust

• Board Members / Advisors• Service Providers• Other Funds - Syndicators• Banks ??????

• Internet - Company and Data Base Linkages• Focused Conferences and Networking• Trade Shows - Suppliers• Business, Technical and Trade Periodicals• University Affiliations - Incubators / Professors• Good Web Sites • Venture Capital Associations

Know Your Venture Fund Model

Page 15: February 4, 2003 Georgetown University Medical Center The Anatomy

15

Presentation, Screening and Analyzing

• Screening - Limit Time and Costs - 1 % Make It• Establish Formal Criteria and Process - In, Out, Maybe• Establish Log- Acknowledge Receipt of Plan Quickly• Out / Rejected Plans - Reasons - Market Too Small, Return

Inadequate, No Personal Risk• In / Maybe - Good reference, Solves Big Pain,

Experienced Management• Initial Interview - “Gut” Reactions to Team - Negotiations

Begin• Provide Feed Back- Be Straight• Move to Due Diligence - Check Existing Portfolio for

Conflicts

Page 16: February 4, 2003 Georgetown University Medical Center The Anatomy

16

Letter of Intent

• Used in Early Days of Venture Capital

• Pre Term Sheet Negotiations

• Informal – nonbinding letter agreement on the sticky issues

• Entrepreneurs and VC resolve business and personality conflicts

Page 17: February 4, 2003 Georgetown University Medical Center The Anatomy

17

Due Diligence

• Verifying the Market - Whose Numbers ? / Related Markets• Who and Where are the Customers ?• Is Management for Real ? - Going Beyond Official References• Can Management be Coached as the Company Grows ?• Do Financial Numbers and Assumptions Make Sense - Valuation?• Are the market and financial strategies Simple to Understand ?• Does the idea ease a Big Enough Pain ?• Always “Kick the Tires” - site visits, wheat in the silos?• Talk to Management and Employees Separately - Employees Know A Lot - Ask Every Question You Can To All Related Parties• Check Former Bankers (Personal and Business) and Suppliers /

Creditors

Page 18: February 4, 2003 Georgetown University Medical Center The Anatomy

18

VC Variables in Valuation:

· ROI need· Amount to be invested· Number of years to hold investment· Actual after-tax profits in harvest / exit year· Price / earnings multiples at time of harvest / exit· Seed / start-up = 50-100% ROI in 10 years + Hold Period· First Stage = 40-60% ROI in 5-10 year Hold Period

Page 19: February 4, 2003 Georgetown University Medical Center The Anatomy

19

Example:Company Profile:· No history of earning· Age similar to public / private company· Technology and market similar· Find like company, etc.

Page 20: February 4, 2003 Georgetown University Medical Center The Anatomy

20

Formula:· Investment = $1,500,000· VC rate of return expected = 40%· After-tax profits in Year 3 = $550,000· Similar companies, etc.:

6x – 8x Net Income in Year 3· Value in Year 3:$550,000 x 6 = $3,300,000 $550,000 x 8 = $4,400,000

· Present Value Formula:(PV = present value, FV = future value, i = investment rate of return, and n = number of years the investment is held)

PV = FV (1 + i) n

$1,500,000 = FV = FV (1 + 0.40) 3 2.744

FV = $4,116,000 or 40% for 3 years

Page 21: February 4, 2003 Georgetown University Medical Center The Anatomy

21

Determination of VC Equity Ownership:

For the investor to receive its return objective, it needs to receivefor its investment a portion of the company. For example, if theventure is worth $3,300,000 to $4,400,000 at the end of yearthree, the $1,500,000 put into the venture by the investor todayshould buy from 34 percent to 45 percent of the company:

$1,500,000 = 34%

$4,400,000or:

$1,500,000 = 45%$3,300,000

Page 22: February 4, 2003 Georgetown University Medical Center The Anatomy

22

Post Closing VC Strategies

• Verifying Use of Proceeds - Follow the Money• Open Communication with Management on Regular Basis• Monthly Reports - Short Narratives Essential• Quarterly Financials - Highlighting Changes from the Plan,

Cash Flow Position, Cost of Operations, Marketing• Anticipate Next Rounds - Check the Term Sheet Milestones• Verify Strength of Management and Ability to Work as a

Team• Test Morale of Employees• Check How Fast Competitors are Growing

Page 23: February 4, 2003 Georgetown University Medical Center The Anatomy

23

Danger Signals and Red Flags

• Weakening Management - Losing Top People• Production Schedules Off - Quality Down• Contracts / Sales Not Booked Timely• Bank Debt Being Restructured• Supplier Terms Being Extended• Change in Auditors• Margins Narrowing• Significant Meetings Changed or Postponed Becoming a Pattern• Top Managers Taking on New Duties without Delegations• High Percentage of Milestones Being Missed• Need to Change CEO - A Delicate Balance

Page 24: February 4, 2003 Georgetown University Medical Center The Anatomy

24

SummaryDeal Breakers vs. Makers

• Deal Breakers- Different Stories – Management vs. Employee- Critical Misrepresentation- Team Never Worked Together- Founders Not Coachable- Inflexibility- Need 100 % of Company – Even if not growing

• Deal Makers- Consistent Pitch- Clean Due Diligence- History of Making Goals- “Skin” is in the Game- Flexibility- Accept 60-40% of a Large Valued Jointly Built Company

Page 25: February 4, 2003 Georgetown University Medical Center The Anatomy

25

Term Sheet / Investment Agreement

• Valuation Terms• Investment Instruments• - Common Stock• - Preferred Stock (Series A, B, C)• - Convertible Preferred• - Convertible Debenture• - Debt with Warrants/Options• Positive/Negative Covenants• Reporting Requirements – Milestones?• Board Seat• Reserve Shares for Employee Incentives – • Stock Options – In or Out• Public Offering Rights, Rights of First Refusal, • Tag Along Rights

Page 26: February 4, 2003 Georgetown University Medical Center The Anatomy

26

ExitingGetting Out - VCs and Founders

• Structure Up Front - Timing Options / Reality Bites• Management Buy Backs - Basis Realistic ??• Purchase Arrangement - Cash Vs. Stock Vs. Debt• Merger Potential - Terms and Conditions - Who wins ?• Exchange Listing - Timing Essential / NASDAQ / GDRs• Distribution Needs of Investors - Supersedes Portfolio

and VC Management Needs ??

Page 27: February 4, 2003 Georgetown University Medical Center The Anatomy

27

Where are we going withBiotechnology and Life Science

Deals?• Breakup Of Early Biotech• Mergers / Acquisitions / Sales• Spin Off Of New Niche Products / Services• Young Ph.D.s And New Enterprise• Development Of Scientist VC• New Deal Structures Based On Science

Business Life Cycle• International Nuances

Page 28: February 4, 2003 Georgetown University Medical Center The Anatomy

28

Bioscience Business Lifecycle and Montgomery College Life Science and Technology Park Ecosystem

Timespan of Phase

MC Contribution in the Phase

MC Benefits in the Phase

MC Bioscience Park Percentage Occupancy

Zero Profit Line

Jerry Feigen, Lloyd Case

New, startup seed-capital, promising,

company

<<< 1-5 Years >>>

*Technology Development

*Entrepreneurial training of staff

*Incubator support:: space, VC contact, business networking

*Students for jobs, interns

*Pipeline to labor pool

*Student intern experience

*Student entrepreneurial education

*Educational cooperation

*Pipeline of education, opportunity

*Equity in early, new company

3%( 30,000 of 1,000,000 sf) or

(25 companies at 1,200average sf)

Young, growing, 1st-2nd round

financed company

<<< 5-10 Years>>>

*Technology Transfer

*VC contacts, education

*Support: space, business networking

*Students for jobs, interns

*Pipeline to labor pool

*Student intern experience

*Student entrepreneurial education

*Rental revenue

*Educational cooperation

*Pipeline of education, opportunity

22%

( 220,000 sf of 1,000,000 sf) or (27 companies at

8,000 average sf)

$uccessful, public, acquisition, or merged anchor

company

*Spinoff new companies

*Mentorships for businesses and students

*Increased rental income

*Educational cooperation

*Pipeline of education, opportunity

*Community advocacy

35%

( 350,000 sf of 1,000,000 sf) or (2-3 companies at

75,000-120,000 average sf)

Mature, Pre-IPO nth-round financed

company

<<< 10+ Years >>>

*Technology Commercialization

*VC contacts, education

*Space, business networking

*Students for jobs, interns

*Pipeline to labor pool

*Student intern experience

*Student entrepreneurial education

*Rental and partnership revenue (return on equity)

*Educational cooperation

*Pipeline of education, opportunity

40%

( 400,000 sf of 1,000,000 sf) or (26 companies at

15,000 average sf)

Page 29: February 4, 2003 Georgetown University Medical Center The Anatomy

29

• Macklin Partners • Technology Council of Maryland• Dingman Center for Entrepreneurship• Montgomery County Department of

Economic Development

• Potential Internships

• Incubator Development

Page 30: February 4, 2003 Georgetown University Medical Center The Anatomy

30

Center for Entrepreneurship

Jerry Feigen, Director 51 Mannakee Street

Rockville, Maryland 20850Phone: 301 738-1702

Fax: 301 279-5149Email: [email protected]

Web: www.macklin.org

For copies of this presentation or further information, contact [email protected]

or 301 738-1707